Abstract
Nitrotyrosine is used as a marker for the production of peroxynitrite and other reactive nitrogen species. For over 20 years the presence of nitrotyrosine was associated with cell death in multiple pathologies. Filling the gap between correlation and causality has proven to be a difficult task. Here, we discuss the evidence supporting tyrosine nitration as a specific posttranslational modification participating in the induction of cell death signaling pathways.
Keywords: Tyrosine nitration, Cell death, Reactive nitrogen species, Peroxynitrite, Nitrated Hsp90
Introduction
The perception of oxidants and free radicals in biological systems underwent important transformations in the last few years. Growing empirical evidence challenges the old dogma that free radicals and oxidants are simple unwanted byproducts of oxygen metabolism. Reactive species produced at low rates, leading to low concentrations within the cells can act as messengers involved in a number of cellular functions [1]. In contrast, overproduction of reactive species leads to oxidative damage associated with many pathological conditions including heart disease, inflammation and neurodegeneration [2, 3]. However, how oxidants and free radicals induce cell death remains highly controversial. It is pending to determine whether these reactive species trigger cell death by massive unspecific damage or through the modification of a limited number of specific cellular targets. Even more basic questions such as whether oxidation of macromolecules plays a role in the induction of cell death or is simply a consequence of the process of cell death is still under debate. In spite of their identity, it is accepted that reactive species exert their action through the oxidative modification of macromolecules in the cells. The nature, identity, selectivity and consequence of these modifications are the matter of profuse research and speculation [4–10]. In fact, the relevance of some oxidants and oxidative modifications in cell signaling has been dismissed due to the oxidants high reactivity and the irreversible nature of the oxidative modifications [10]. On the other hand, the prolonged half-life of these modifications could be advantageous in some conditions. There are permanent post-translational modifications that are widely accepted as events contributing to cell signaling. Some kinases are activated by partial proteolysis and inactivated by degradation [11–14]. Similarly, the endoproteases of the caspase family are activated also by partial proteolysis, which leads to a highly regulated proteolytic cascade responsible for apoptosis [15, 16]. These long-lived posttranslational modifications have profound consequences in the signaling pathways carrying the cellular machinery in one defined direction. However, even the activation of caspases is not always irreversible since the cells have inhibitor of apoptosis proteins (IAP) that can inhibit caspase activation and prevent cell death [15, 17]. In the case of tyrosine nitration, there is some evidence that the modification can be removed in certain conditions, though the mechanism remains unknown [18].
Defining the role of oxidative stress in cell death has been extremely difficult because of the multiplicity of potential targets that can be damaged by oxidation. Yet, oxidants can be surprisingly selective and act as second messengers, as described by Carl Nathan in his essay on “Specificity of a third kind” [19]. Every macromolecule in the cell is a possible target of oxidative damage, and massive oxidative damage to any macromolecule is enough to induce cell death. It is generally accepted that massive unspecific damage to DNA, proteins or lipids is enough to produce necrosis. Nonetheless, oxidative damage also activates stereotyped mechanism of cell death such as autophagy and apoptosis [20–23]. The question that remains to be answered is whether the cell senses unspecific damage and then activates the cell death program or the modification of key cellular components by oxidation is what leads to the activation of the programs.
In this review we revisit 20 years of literature, from the original description of peroxynitrite-induced cell death to the role of tyrosine nitration and the discovery of the first nitrated protein responsible for the activation of specific cell death pathways.
Reactive oxygen and nitrogen species
Oxidants and free radicals are frequently named as reactive species and grouped based on the atom that is more reactive and/or that originates the molecule. Free radicals are molecules with one or more unpaired electrons, while oxidants are molecules with a high potential for taking electrons from other molecules. Typical examples of free radicals with one unpaired electron are superoxide and nitric oxide. Oxygen on the other hand has two orbitals with one unpaired electron, which make it a di-radical [24]. The reactivity of members of the different “families” varies greatly and depends on the environment. In biological relevant conditions, some molecules such as superoxide are poor oxidants. However, in the presence of nitric oxide, superoxide forms the strong oxidant peroxynitrite in a diffusion-limited reaction [38]. The oxidant hydrogen peroxide in the absence of transition metals oxidizes only specific cysteine residues. However, in the presence of transition metals it forms the strong oxidant hydroxyl radical. In spite of the differences of reactivity, oxidants and free radicals are classified into several families of reactive species. The best-known examples are the reactive oxygen species (ROS), which originate by reduction of oxygen, and reactive nitrogen species (RNS), which are derived from the free radical nitric oxide.
Nitric oxide is produced from arginine by the three isoforms of nitric oxide synthase (NOS). Nitric oxide reacts with ROS to generate a variety of compounds with a very complex chemistry, previously reviewed in depth [2, 25, 26].
Most of these radicals and oxidants are produced in the cell during normal conditions and were traditionally considered aberrant byproducts of normal metabolism. In recent years it has been shown that some of them are not the byproduct of metabolism, but produced by the cell as intracellular and intercellular messengers. Nitric oxide was the first free radical with incontrovertible signaling functions in the regulation of blood vessel relaxation [27–29]. Further research showed that hydrogen peroxide also has important signaling functions [1]. Nonetheless, the literature and the experimental designs call for careful analysis due to the use of high concentrations of hydrogen peroxide as well as the lack of specificity of the methods employed to detect the oxidant [30, 31].
The identification of non-damaging regulatory oxidative modifications of proteins led to the concept of oxidative regulation of cellular processes and oxidative signaling. Oxidation of protein residues such as cysteine is now an accepted posttranslational modification. Nitrosation involves the oxidation of thiol groups on cysteine residues by nitric oxide. Cysteine nitrosation regulates the function of a number of proteins and is probably one of the more common mechanisms by which nitric oxide regulates cell metabolism [10, 32–35]. Similarly, hydrogen peroxide production leads to the oxidation of cysteine and other residues. Proteins with specific oxidized cysteine residues are now considered signaling molecules responsible for the regulation of a variety of normal cellular functions [1, 10, 30, 36]. In contrast, a more general oxidation of thiolates and other residues is present in pathological conditions. Although in most cases the mechanisms that give specificity to the reactions are not fully understood, even in normal physiological conditions not every residue that is oxidized participates in signal transduction. Many residues act like decoys or scavengers for the oxidants, as is the case of the cysteine in the active site of the peroxiredoxin family of peroxidases [37]. Growing evidence strongly suggests that the oxidant peroxynitrite is also an intra-cellular messenger [38–40].
Tyrosine nitration
Nitrotyrosine is a footprint left by peroxynitrite and other reactive nitrogen species [2, 41–44]. The mechanisms of tyrosine nitration are well understood, even though the relative participation of each mechanism in vivo is unknown (Fig. 1). Nitrotyrosine is present in a variety of human diseases and animal models of human diseases [4, 8, 45–49]. It is also present in inflammatory conditions such as multiple sclerosis [50–53], spinal cord injury, stroke and ischemia/reperfusion [54–59]. Although amply described in pathological settings, the presence of nitrotyrosine is not limited to disease since this oxidative modification can also be found in physiological conditions [40, 44, 60].
Fig. 1.
Mechanisms of protein tyrosine nitration in the cell and the effect on protein function. In the cells, the incorporation of a nitro group on a tyrosine residue can occur through different mechanisms. All mechanisms of nitration but one involve a double hit by radicals, the first forming the radical tyrosyl. The second reaction is a radical–radical reaction between the radical tyrosyl and nitrogen dioxide (.NO2). Nitration could be mediated by the radical products of decomposition of peroxynitrite nitrogen dioxide and hydroxyl radical (·OH). The exception for the two radical hit is the nitration catalyzed by transition metals or peroxidases. Peroxynitrite can react also with bicarbonate () to form oxoperoxocarbamato, whose radical products of decomposition efficiently nitrate tyrosine residues. Nitrite () and hydrogen peroxide (H2O2) can also nitrate tyrosine residues in the presence of transition metals or peroxidases. Depending on the location of the tyrosine residue, nitration of that residue may not have a functional consequence, or the protein may be inactivated, activated or may gain a new function
Dozens of nitrated proteins in vivo have been identified by mass spectrometry [2, 45]. The lack of tools to identify specific targets and methods to recapitulate the specific forms of oxidative modification or damage has greatly limited the comprehension of the role that nitrative stress plays in pathology. Not all tyrosine residues are equally probable to be nitrated. Location and microenvironment also play an important role. For nitration to occur the tyrosine residue must be ionized, exposed and the conditions that stabilize the tyrosyl radical as well as the intermediates that allow the nitrogen dioxide attack must be present [61, 62]. In addition, the amount of a protein and the tyrosine content are not predictors of the level of nitration [4, 61, 63, 64]. We have shown that in a simple tetrapeptide, replacement of arginine by alanine is enough to decrease 20 % the efficiency of nitration by peroxynitrite in the presence of bicarbonate, suggesting that some of the specificity is the consequence of the tyrosine environment [65].
Peroxynitrite and cell death
Shortly after the discovery of peroxynitrite and nitrotyrosine in biological systems [38, 66], several independent groups almost simultaneously reported that incubation of various cell types with exogenous peroxynitrite induces apoptosis or necrosis depending on the concentration of the oxidant [67–70]. Endogenous production of peroxynitrite by downregulation of Cu, Zn superoxide dismutase in PC12 cells, or trophic factor deprivation and Fas receptor activation in motor neurons results also in the activation of apoptosis [71–74]. In all these conditions, nitration of tyrosine residues always precedes peroxynitrite-induced apoptosis. One important observation is that peroxynitrite activates specific pathways for the induction of apoptosis. In PC12 cells, the incubation with peroxynitrite has different effects on cell death depending on the interaction with specific signal transduction pathways (Table 1). Pre-incubation of PC12 cells with nerve growth factor (NGF) or insulin protects the cells from peroxynitrite-induced apoptosis. Similarly, the incubation with insulin immediately after exposure to peroxynitrite is also protective. Conversely, pre-incubation of the cells with fibroblast growth factor (FGF) or incubation with NGF immediately after exposure to peroxynitrite results in increased cell death [69, 75–77]. These results reveal specific and selective interaction of peroxynitrite with signaling pathways activated by the different trophic factors. In fact, FGF added immediately after peroxynitrite or endothelial growth factor added at anytime does not modify the effects of peroxynitrite on cell death. These results suggest that peroxynitrite activates specific intracellular signaling pathways to stimulate apoptosis rather than just causing unspecific molecular oxidation.
Table 1.
Interaction of trophic factors with peroxynitrite in the induction of cell death
Trophic factor | Effect on survival after incubation with peroxynitrite | |
---|---|---|
Before | After | |
NGF | ↑↑ | ↓↓ |
Insulin | ↑↑ | ↑↑ |
IGF1 | ↑↑ | ↑↑ |
FGF1 | ↓ | = |
FGF2 | ↓ | = |
EGF | = | = |
↑ Prevents cell death; ↓ enhances cell death; = No effect
Tyrosine nitration as mediator of peroxynitrite-induced cell death
As mentioned before, tyrosine nitration is present under pathological conditions but whether it plays a causative role or is merely collateral damage has been difficult to determine. Tyrosine does not react directly with peroxynitrite, but with peroxynitrite-derived radicals such as carbonate radical and nitrogen dioxide [44, 65, 78–80] (Fig. 1). However, in the presence of transition metals peroxynitrite can directly nitrate tyrosine residues [81]. In addition, tyrosine residues can also be nitrated by myeloperoxidase using hydrogen peroxide and nitrite as substrates [82, 83]. To directly assess the role of tyrosine nitration on cellular physiology and cell death, we developed tyrosine-containing peptides that act as a “decoy” for the nitrating species derived from peroxynitrite. The amino acid sequences of the peptides were based on known nitration sites from endogenously nitrated proteins. In vitro, these peptides did not scavenge peroxynitrite, but prevented nitration of proteins in cell and tissue homogenates. When delivered intracellularly, peptides containing tyrosine, but not phenylalanine or proline, prevented motor neuron apoptosis induced by trophic factor deprivation and peroxynitrite-induced PC12 cell apoptosis [65] (Fig. 2). From the peptides tested, only those containing tyrosine or tryptophan residues were protective against peroxynitrite-induced cell death but had no effect on hydrogen peroxide- or staurosporine-induced apoptosis. In addition, the peptides did not prevent glutathione oxidation by peroxynitrite in PC12 cells and in vitro [65], in agreement with being unable to scavenge peroxynitrite. As expected, thiol-containing compounds such as N-acetyl cysteine and glutathione prevented peroxynitrite-induced apoptosis. The direct reaction of peroxynitrite with thiols makes these compounds excellent scavengers of the oxidant [79, 84]. Moreover, the scavengers of lipid peroxyl radicals, vitamin E and the soluble analogue trolox, did not provide protection against peroxynitrite-induced apoptosis, suggesting that lipoperoxidation is not involved in peroxynitrite-induced apoptosis. Thus, tyrosine-containing peptides do not prevent thiol oxidation but tyrosine nitration. Collectively, these results suggest that peroxynitrite-induced apoptosis is mediated by the nitration of tyrosine residues in proteins.
Fig. 2.
Role of tyrosine nitration in peroxynitrite-induced apoptosis in PC12 cells and motor neurons. Nitration of tyrosine residues has been implicated in the induction of cell death upon exogenous addition or endogenous production of peroxynitrite. In PC12 cells, peroxynitrite treatment leads to the simultaneous inactivation of the PI3K/Akt pathway and the activation of the p38-MAPK and JNK pathways, ultimately inducing cell death. In motor neurons, the endogenous production of peroxynitrite upon trophic factor deprivation leads also to cell death. In both cases, intracellular delivery of tyrosine-containing peptides is protective, suggesting that peroxynitrite-induced cell death is mediated by tyrosine nitration
Tyrosine nitration, protein function, and cell death: correlation or causality?
Not all the tyrosine residues on a protein are prone to nitration. In fact, a very small number of tyrosine residues are nitrated in inflammatory conditions. During inflammation only 100–500 μmol of nitrotyrosine per mole of tyrosine residue can be detected [85]. Depending on the surrounding microenvironment and accessibility, some tyrosine residues will be preferential targets of nitration. In addition, constitutive proteins that are highly expressed in the cells, such as actin and heat shock proteins, constitute primary targets probably due to their abundance [2, 65]. Modifications of enzymes that reduce the total activity by 1 % are most likely not significant, but modifications that significantly reduce protein activity, activate an enzyme or cause gain-of-function may be highly significant. As detailed below, nitration of specific tyrosine residues causing protein loss or gain-of-function has been correlated with cell death.
The best-described effect of tyrosine nitration on proteins is the inactivation or loss of function. Twenty years ago manganese superoxide dismutase (MnSOD) was the first protein described as a target of tyrosine nitration and inactivation in vivo during human kidney allograft rejection [86]. This protein is particularly susceptible to nitration because the manganese atom in the active site catalyzes the nitration of the tyrosine residue, which results in the loss of activity [86, 87]. Nitration of tyrosine 34, located in the active site of the protein, completely inhibits MnSOD enzymatic activity upon treatment with peroxynitrite [88, 89]. Interestingly, shortly after this tyrosine was identified it was shown that its conservative replacement by phenylalanine, an amino acid resistant to nitration, failed to protect MnSOD from peroxynitrite-mediated inactivation, suggesting that tyrosine nitration was not the only oxidative modification involved in MnSOD loss of function [87].
One of the most important barriers for the study of oxidative modifications is that the incubation of proteins with any oxidant produces a variety of oxidative products that are not homogenously modified. Tyrosine nitration may be achieved by different methods, but other residues such as tryptophan and cysteine will also be oxidized. In addition, even if a protein contains only a few tyrosine residues, there is no certainty that all the molecules will be homogeneously nitrated in all sites. Then, it is difficult to assign an effect to the modification of one residue. The recent development of a method for the incorporation of the non-natural amino acid nitrotyrosine into recombinant proteins provides a new powerful tool to solve all these pitfalls [90]. Using this methodology, it was demonstrated that the presence of nitrotyrosine in position 34 as the sole modification on MnSOD inhibits 97 % of the superoxide dismutase activity of the enzyme. This finding raises the question as to how reliable the substitution of amino acids is when studying oxidative modifications, considering that protein folding and amino acid microenvironment is key to the final result.
Over the years, MnSOD tyrosine nitration has been observed in several pathologies and animal models, including renal and hepatic ischemia/reperfusion, acute rejection of cardiac transplants, cardiovascular disease, aging, human brain injury, and cyclosporine A-related vascular toxicity [91–96]. This enzyme is in the mitochondrial matrix at 10–20 μM concentrations, and is particularly relevant to the mitochondrial metabolism [97, 98]. The genetic deletion of the MnSOD gene is early lethal [99]. However, mice heterozygous for the deletion of the MnSOD, which has 50 % MnSOD activity, show increased susceptibility to mitochondrial oxidative damage and increased apoptosis at younger ages than wild type mice [100]. In the setting of a pathological condition, this means that for MnSOD inactivation to be relevant as cause of cell death, more than 50 % of the enzyme should be nitrated and inactivated. The nitrating products from one molecule of peroxynitrite can nitrate only one tyrosine residue and the efficiency of nitration in vitro is between 10 and 30 %, but in some cases can achieve 100 % [80], meaning that the nitration of one tyrosine residue requires the production of 1–3 molecules of peroxynitrite. Applying these calculations to the nitration of only one tyrosine in MnSOD, the concentration of peroxynitrite-derived radicals produced in a cell should be at least equal to the concentration of MnSOD, considering the more efficient nitration conditions [80]. In this context, it is possible to speculate that peroxynitrite should be either acutely produced at over 10 μM concentrations, or the steady-state concentration of peroxynitrite should be sustained over time to compensate for the MnSOD protein turnover. Given that these conservative calculations do not consider endogenous scavengers of peroxynitrite such as thiols and competing tyrosine residues in other proteins, achieving conditions in which more than 50 % of the MnSOD is inactivated would require extreme circumstances most probably associated with catastrophic pathological conditions.
Nitration and inactivation of other enzymes involved in antioxidant mechanisms, such as thioredoxin-1 (Trx-1), has also been associated with cell death. Trx-1 is a small, 12 kDa oxidoreductase protein involved in redox metabolism. Trx-1 is ubiquitously expressed in cells. Human Trx-1 contains a single tyrosine residue at position 49 [101]. Nitrated Trx-1 is detected in cardiac tissue subjected to ischemia/reperfusion, and nitration of this tyrosine residue in vitro decreases Trx-1 activity by 80 % [102]. Administration of recombinant human Trx-1 proved to be cardioprotective in a myocardial ischemia/reperfusion animal model [102, 103]. Interestingly, administration of nitrated Trx-1 failed to protect myocardial tissue from apoptosis. Replacement of tyrosine 49 by phenylalanine was enough to restore the cardioprotective role of Trx-1 upon treatment of the protein with the NO and superoxide donor 3-morpholino-sydnonimine (SIN-1) [102], suggesting that nitration of tyrosine 49 and inactivation of Trx-1 contributes to postischemic cardiomyocyte apoptosis. However, the authors used exogenous enzyme to test the protective effects and inactivation of the enzyme. There is neither quantification of endogenous nitration nor investigation of how much enzyme should be inactivated for the cells to die reported in the manuscript. In these conditions, it can only be established a correlation between the presence of the nitrated protein in disease conditions, but not a causal relation between the nitration of the enzyme and the disease.
The induction of structural changes by tyrosine nitration on proteins involved in apoptotic processes may also play a role in the regulation of cell death. Nitration of the mitochondrial protein cytochrome c occurs in vitro upon treatment with peroxynitrite [104] and in vivo when reactive nitrogen species are endogenously produced [91, 105]. Nitration of the solvent-exposed tyrosine 74 induces structural changes that may have an impact on cytochrome c function [106]. Interestingly, in the presence of nitrite and hydrogen peroxide, cytochrome c can catalyze its own nitration as well as nitration of adjacent proteins such as MnSOD [107]. In in vitro studies, nitrated cytochrome c fails to assemble a functional apoptosome [108, 109]. Similarly, replacement of all but one tyrosine residue at either position 46, 48, or 74 by phenylalanine in the human cytochrome c prevents caspase 9 activation [110, 111]. However, nitration of tyrosine 46 and 48 has not been described to occur in vivo and nitration of these residues seems to induce degradation of the nitrated protein [112]. Whether nitration of cytochrome c is relevant to the regulation of cellular apoptotic processes in vivo is still being investigated.
Tyrosine hydroxylase (TH) is another protein whose loss of function by tyrosine nitration was linked to cell death several years ago. This enzyme is the rate-limiting enzyme in dopamine synthesis. Decreased dopaminergic function in neurons that undergo neurodegeneration is a hallmark of Parkinson’s disease (PD). In a mice model of PD, the loss of TH activity correlates with an increase in tyrosine nitration and a decrease in dopamine levels [113]. Indeed, peroxynitrite treatment induces TH loss of enzymatic activity in vitro. The enzymatic inhibition can be prevented by the conservative replacement of tyrosine 423 on TH by phenylalanine [114]. Although these results make a strong case for the role of tyrosine nitration in the lost functionality of dopaminergic neurons in Parkinson’s disease, two key issues remain to be elucidated. The first is the proportion of TH that is inactivated in pathological conditions to determine whether it would produce a significant alteration in the production of dopamine. The second is to establish a relation between the nitration of TH and the induction of cell death.
As with other post-translational modifications, tyrosine nitration on certain proteins can induce a gain-of-function, one that the unmodified protein cannot perform. This is the case of α-synuclein and heat shock protein 90 (Hsp90). The presence of nitrated α-synuclein in inclusion bodies in PD, dementia, and Alzheimer’s disease was described more than 10 years ago [115]. Nitration of α-synuclein has been proposed to be responsible for the aggregation and toxicity of this protein in these synucleinopathies [115, 116]. Indeed, nitrated α-synuclein was detected in vivo in the substantia nigra of old primates (>16 years of age) but rarely in adult mature animals (<10 years of age) [117]. In addition, nitrated α-synuclein evades immunological tolerance, activating an immune response that in turn accelerates nigral dopaminergic neuron degeneration [118]. The recombinant protein used in this report was nitrated using a final peroxynitrite concentration of 5 M in the presence of 5 mM iron. These extreme oxidative conditions should surely produce other oxidative modification in the recombinant protein that can participate in the gain of toxic function. Important controls using α-synuclein with the tyrosine residues replaced by phenylalanine show that tyrosine nitration is necessary. However, whether tyrosine nitration is sufficient to induce the gain-of-function is not evident from these experiments.
Nitration and oxidation of α-synuclein induce highly stable oligomer formation in vitro and stabilize pre-assembled α-synuclein filaments increasing the formation of aggregates [119]. Dimers and polymers of α-synuclein nitrated at all tyrosine residues (tyrosine 39, 125, 133 and 136) trigger cell death when exogenously added to the human neuroblastoma cell line SH-SY5Y at 5 μM concentration. Nitrated α-synuclein binds to integrin on the cell membrane, increases inducible NOS expression and activity, and decreases phosphorylation of focal adhesion kinase (FAK), followed by activation of caspase 3 [120]. The nitration of α-synuclein in this report was performed incubating with NaNO2 for 7 days by a non-described mechanism. Alpha-synuclein nitrated by this method was characterized using western blot and mass spectrometry. However, there is no information showing the complete mass spectrometric analysis of the protein to dismiss other possible oxidative modifications or other type of modification due to the long incubation.
Nitrated Hsp90 is an effector in peroxynitrite-induced apoptosis
As detailed above, nitration of tyrosine residues on several proteins has been associated with induction of cell death. Nonetheless, demonstrating causality rather than a correlation between nitration and cell death has proven difficult to achieve. The main reasons are the number of potential oxidative and nitrative modifications and the lack of tools to assess the role of tyrosine nitration as the sole modification on a protein. By intracellularly delivering tyrosine-containing peptides as nitration decoys we were the first to demonstrate that tyrosine nitration did play a role in peroxynitrite-induced cell death (Fig. 2). At that time, the nitrated proteins that were the actual effectors in the induction of cell death remained unknown. Recently, we identified one of such nitrated proteins. We showed that nitration of a single tyrosine residue on Hsp90 turns this pro-survival chaperone into a toxic protein [121]. This is the first demonstration that tyrosine nitration on a specific protein plays a role in the induction of cell death, establishing causality rather than correlation.
Hsp90 is a ubiquitous molecular chaperone present in all eukaryotic cells [122]. It is expressed at high concentrations constituting 1–2 % of the total cytosolic protein [123]. Most proteins in the cell require Hsp90 for folding, stabilization, activation or repression, degradation, and translocation to subcellular compartments [124, 125]. Due to this vast array of functions, Hsp90 is necessary for cell survival and proliferation [126]. Structurally, Hsp90 has three distinctive domains: N-terminal domain (ND), where the ATP-binding pocket resides, middle domain (MD), responsible for the binding to client proteins, and C-terminal or dimerization domain (CD) [127]. Functionally, Hsp90 is a dimer that binds client proteins and hydrolyze ATP in a complex cycle with several intermediate conformations. Amino acids from the different domains interact and are crucial to this Hsp90 ATPase cycling [125, 127]. The human Hsp90 sequence has 24 tyrosine residues, five of which are target of nitration [121]. Two of these residues, tyrosine 33 and 56 in Hsp90β are located in the ND, near the ATP binding pocket (Fig. 3). By using a new, state-of-the-art technology that allows the genetically encoded incorporation of nitrotyrosine into proteins at specific positions [90], we were able to express a recombinant human Hsp90 with nitrotyrosine at position 33 or 56. The presence of nitrotyrosine at either of these positions as the sole modification on Hsp90 proved to be necessary and sufficient to turn the chaperone from a pro-survival to a pro-apoptotic protein. Similar results were obtained by intracellularly delivering a peroxynitrite-treated Hsp90 in which 4 tyrosine residues were replaced by phenylalanine, maintaining either tyrosine 33 or 56 intact [121].
Fig. 3.
Induction of cell death by nitrated Hsp90. The intracellular delivery of peroxynitrite-treated Hsp90 induces cell death by the activation of a novel P2X7/Fas pathway. The genetically directed incorporation of nitrotyrosine at either position 33 or position 56 confirmed that the incorporation of a single nitrotyrosine on Hsp90 is sufficient to induce cell death
The prediction from 3D modeling analysis is that nitration of tyrosine 56 should impair ATP binding to Hsp90, while tyrosine 33 (tyrosine 24 in yeast) plays a crucial role during Hsp90 ATPase cycle [128]. Indeed, peroxynitrite-treated Hsp90 retains only 20 % of the ATPase activity compared to unmodified Hsp90 [121]. Intracellular delivery of nitrated Hsp90 at a concentration as low as 5 % of the total endogenous Hsp90 is sufficient to induce cell death, implying that the nitration of Hsp90 causes a gain-of-function. Interestingly, trophic factor deprivation stimulates the nitration of 5 % of total Hsp90 in cultured motor neurons before the induction of apoptosis, but at the time the cells are committed to die. In these cells, nitrated Hsp90 induces cell death by activating P2X7 receptor, which in turn activates the Fas/Fas ligand cell death pathway [121] (Fig. 3). By developing an antibody that recognizes Hsp90 when nitrated at position 56 we detected the toxic protein in vivo in pathological conditions such as amyotrophic lateral sclerosis and spinal cord injury [65, 121]. This is the first demonstration that nitration of specific tyrosine residues on a specific protein activates apoptotic pathways and induces cell death.
Concluding remarks
There is the general, widely accepted idea that RNS induce cell death by simultaneously causing general oxidative damage to multiple cellular components. Depending on the concentration at which they are produced and the cellular context, RNS can indeed cause such damage, leading to cell death by necrosis. However, there is a more subtle and relevant biological aspect to RNS that has only recently started to surface. Over the years, others and we have shown that RNS can stimulate apoptosis through the activation of tightly regulated pathways. More and more evidence supports the concept of RNS acting as second messengers in the regulation of cellular metabolism. In the last 20 years, tyrosine nitration has been detected in numerous pathologies in the cell types or tissues most affected by the disease. In addition, tyrosine nitration can lead to protein inactivation. As a consequence, tyrosine nitration was naturally associated with cell death without empirical evidence showing causality rather than correlation. Only recently, the first nitrated protein playing an actual role in the induction of cell death was described. Tyrosine nitration is the switch turning a pro-survival protein such as Hsp90 into an executioner of cell death. Several reports have shown that tyrosine residues can be reduced and the nitro group removed, though the enzymatic activity responsible for this activity has not been determined [18, 129]. These observations suggest that tyrosine nitration can also be regulated by means other than protein degradation. It can be hypothesized that some tyrosine residues are functional targets for nitration, while the vast majority of nitration is just a protective mechanism to secure specificity of the signals. The same concept could be applied to other oxidative modifications. In this context, in order to prevent the formation of specific and potentially ‘toxic’ nitrated proteins, most of the nitration targets may act as decoy scavenging the nitrating agents. Thus, only a small amount of any given protein would be nitrated, preserving the total activity and function of that protein. In addition, it is possible that as some residues in some proteins evolved to be nitrated as a signaling event, some residues in other proteins evolved to act as a decoy for nitration without any effect on protein function. In this context normal protein turnover would be responsible for removing unwanted nitration. It is the modification of specific residues on specific proteins which gives powerful oxidants such as peroxynitrite, the specificity required for them to be second messengers involved in the control of cellular processes. These are some of the new challenges ahead of us to understand the biology of reactive nitrogen species.
Acknowledgments
The authors thank Cassandra Dennys for the critical reading and comments on the manuscript. This work was supported by the Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, the National Institute of Health (NIH Grants NS36761 to A.G.E.) and a Burke Medical Research Institute Goldsmith Fellowship (to M.C.F).
References
- 1.Sies H. Role of metabolic H2O2 generation: redox signaling and oxidative stress. J Biol Chem. 2014;289(13):8735–8741. doi: 10.1074/jbc.R113.544635. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007;87(1):315–424. doi: 10.1152/physrev.00029.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Beal MF. Oxidatively modified proteins in aging and disease. Free Radic Biol Med. 2002;32(9):797–803. doi: 10.1016/s0891-5849(02)00780-3. [DOI] [PubMed] [Google Scholar]
- 4.Ischiropoulos H. Biological selectivity and functional aspects of protein tyrosine nitration. Biochem Biophys Res Commun. 2003;305(3):776–783. doi: 10.1016/s0006-291x(03)00814-3. [DOI] [PubMed] [Google Scholar]
- 5.Perluigi M, Fai Poon H, Hensley K, Pierce WM, Klein JB, Calabrese V, De Marco C, Butterfield DA. Proteomic analysis of 4-hydroxy-2-nonenal-modified proteins in G93A-SOD1 transgenic mice-A model of familial amyotrophic lateral sclerosis. Free Radic Biol Med. 2005;38(7):960–968. doi: 10.1016/j.freeradbiomed.2004.12.021. [DOI] [PubMed] [Google Scholar]
- 6.Kanski J, Hong SJ, Schoneich C. Proteomic analysis of protein nitration in aging skeletal muscle and identification of nitrotyrosine-containing sequences in vivo by nanoelectrospray ionization tandem mass spectrometry. J Biol Chem. 2005;280(25):24261–24266. doi: 10.1074/jbc.M501773200. [DOI] [PubMed] [Google Scholar]
- 7.Massignan T, Casoni F, Basso M, Stefanazzi P, Biasini E, Tortarolo M, Salmona M, Gianazza E, Bendotti C, Bonetto V. Proteomic analysis of spinal cord of presymptomatic amyotrophic lateral sclerosis G93A SOD1 mouse. Biochem Biophys Res Commun. 2007;353(3):719–725. doi: 10.1016/j.bbrc.2006.12.075. [DOI] [PubMed] [Google Scholar]
- 8.Castegna A, Thongboonkerd V, Klein JB, Lynn B, Markesbery WR, Butterfield DA. Proteomic identification of nitrated proteins in Alzheimer’s disease brain. J Neurochem. 2003;85(6):1394–1401. doi: 10.1046/j.1471-4159.2003.01786.x. [DOI] [PubMed] [Google Scholar]
- 9.Butterfield DA. Proteomics: a new approach to investigate oxidative stress in Alzheimer’s disease brain. Brain Res. 2004;1000(1–2):1–7. doi: 10.1016/j.brainres.2003.12.012. [DOI] [PubMed] [Google Scholar]
- 10.Janssen-Heininger YM, Mossman BT, Heintz NH, Forman HJ, Kalyanaraman B, Finkel T, Stamler JS, Rhee SG, van der Vliet A. Redox-based regulation of signal transduction: principles, pitfalls, and promises. Free Radic Biol Med. 2008;45(1):1–17. doi: 10.1016/j.freeradbiomed.2008.03.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Hashimoto E, Takeuchi F, Yamamura H. Studies on protein kinase C tightly-bound to rat liver plasma membrane and its protease-activated form. Int J Biochem. 1991;23(4):395–403. doi: 10.1016/0020-711x(91)90166-k. [DOI] [PubMed] [Google Scholar]
- 12.Hashimoto E, Takeuchi F, Yamamura H. Protease-activated form of protein kinase C with Mr 80,000 generated from rat liver plasma membrane by trypsin-like protease. Biochem Int. 1990;21(5):949–957. [PubMed] [Google Scholar]
- 13.Hashimoto E, Mizuta K, Yamamura H. Protease-activated protein kinase in rat liver plasma membrane. Biochem Biophys Res Commun. 1985;131(1):246–254. doi: 10.1016/0006-291x(85)91795-4. [DOI] [PubMed] [Google Scholar]
- 14.Tapley PM, Murray AW. Platelet Ca2+-activated, phospholipid-dependent protein kinase: evidence for proteolytic activation of the enzyme in cells treated with phospholipase C1. Biochem Biophys Res Commun. 1984;118(3):835–841. doi: 10.1016/0006-291x(84)91470-0. [DOI] [PubMed] [Google Scholar]
- 15.Alenzi FQ, Lotfy M, Wyse R. Swords of cell death: caspase activation and regulation. Asian Pac J Cancer Prev APJCP. 2010;11(2):271–280. [PubMed] [Google Scholar]
- 16.Bratton SB, Salvesen GS. Regulation of the Apaf-1-caspase-9 apoptosome. J Cell Sci. 2010;123(Pt 19):3209–3214. doi: 10.1242/jcs.073643. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Galban S, Brady GF, Duckett CS. Caspases and IAPs: a dance of death ensures cell survival. Mol Cell. 2008;32(4):462–463. doi: 10.1016/j.molcel.2008.11.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Shi Q, Xu H, Yu H, Zhang N, Ye Y, Estevez AG, Deng H, Gibson GE. Inactivation and reactivation of the mitochondrial alpha-ketoglutarate dehydrogenase complex. J Biol Chem. 2011;286(20):17640–17648. doi: 10.1074/jbc.M110.203018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Nathan C. Specificity of a third kind: reactive oxygen and nitrogen intermediates in cell signaling. J Clin Invest. 2003;111(6):769–778. doi: 10.1172/JCI18174. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Ferraro E, Cecconi F. Autophagic and apoptotic response to stress signals in mammalian cells. Arch Biochem Biophys. 2007;462(2):210–219. doi: 10.1016/j.abb.2007.02.006. [DOI] [PubMed] [Google Scholar]
- 21.Kurz T, Terman A, Gustafsson B, Brunk UT. Lysosomes and oxidative stress in aging and apoptosis. Biochim Biophys Acta. 2008;1780(11):1291–1303. doi: 10.1016/j.bbagen.2008.01.009. [DOI] [PubMed] [Google Scholar]
- 22.Ryter SW, Kim HP, Hoetzel A, Park JW, Nakahira K, Wang X, Choi AM. Mechanisms of cell death in oxidative stress. Antioxid Redox Signal. 2007;9(1):49–89. doi: 10.1089/ars.2007.9.49. [DOI] [PubMed] [Google Scholar]
- 23.Filomeni G, Ciriolo MR. Redox control of apoptosis: an update. Antioxid Redox Signal. 2006;8(11–12):2187–2192. doi: 10.1089/ars.2006.8.2187. [DOI] [PubMed] [Google Scholar]
- 24.Halliwell B, Gutteridge JMC. Free radical in biology and medicine. 3. New York: Oxford University Press; 2003. [Google Scholar]
- 25.Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol. 1996;271(5 Pt 1):C1424–C1437. doi: 10.1152/ajpcell.1996.271.5.C1424. [DOI] [PubMed] [Google Scholar]
- 26.Beckman JS. Nitric oxide: principles and actions. In: Lanacaster JR, editor. The physiological and pathological chemistry of nitric oxide. New York: Academic; 1996. pp. 1–82. [Google Scholar]
- 27.Ignarro LJ. Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol Toxicol. 1990;30:535–560. doi: 10.1146/annurev.pa.30.040190.002535. [DOI] [PubMed] [Google Scholar]
- 28.Moncada S, Palmer RMJ, Higgins EA. Nitric oxide: physiology, pathophysiology, phamacology. Pharmacol Rev. 1991;43(2):109–142. [PubMed] [Google Scholar]
- 29.Ignarro LJ. Nitric oxide: a unique endogenous signaling molecule in vascular biology. Biosci Rep. 1999;19(2):51. doi: 10.1023/a:1020150124721. [DOI] [PubMed] [Google Scholar]
- 30.Forman HJ. Use and abuse of exogenous H2O2 in studies of signal transduction. Free Radic Biol Med. 2007;42(7):926–932. doi: 10.1016/j.freeradbiomed.2007.01.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Kalyanaraman B, Darley-Usmar V, Davies KJ, Dennery PA, Forman HJ, Grisham MB, Mann GE, Moore K, Roberts LJ, 2nd, Ischiropoulos H. Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations. Free Radic Biol Med. 2012;52(1):1–6. doi: 10.1016/j.freeradbiomed.2011.09.030. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Nakamura T, Lipton SA. Emerging role of protein–protein transnitrosylation in cell signaling pathways. Antioxid Redox Signal. 2013;18(3):239–249. doi: 10.1089/ars.2012.4703. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Maron BA, Tang S–S, Loscalzo J. S-Nitrosothiols and the S-nitrosoproteome of the cardiovascular system. Antioxid Redox Signal. 2013;18(3):270–287. doi: 10.1089/ars.2012.4744. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Smith BC, Marletta MA. Mechanisms of S-nitrosothiol formation and selectivity in nitric oxide signaling. Curr Opin Chem Biol. 2012;16(5–6):498–506. doi: 10.1016/j.cbpa.2012.10.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Hess DT, Stamler JS. Regulation by S-nitrosylation of protein post-translational modification. J Biol Chem. 2012;287(7):4411–4418. doi: 10.1074/jbc.R111.285742. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Forman HJ, Dickinson DA. Oxidative signaling and glutathione synthesis. Biofactors. 2003;17(1–4):1–12. doi: 10.1002/biof.5520170101. [DOI] [PubMed] [Google Scholar]
- 37.Rhee SG, Chae HZ, Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med. 2005;38(12):1543–1552. doi: 10.1016/j.freeradbiomed.2005.02.026. [DOI] [PubMed] [Google Scholar]
- 38.Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA. 1990;87(4):1620–1624. doi: 10.1073/pnas.87.4.1620. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Calcerrada P, Peluffo G, Radi R. Nitric oxide-derived oxidants with a focus on peroxynitrite: molecular targets, cellular responses and therapeutic implications. Curr Pharm Des. 2011;17(35):3905–3932. doi: 10.2174/138161211798357719. [DOI] [PubMed] [Google Scholar]
- 40.Viera L, Radmilovich M, Vargas MR, Dennys CN, Wilson L, Barnes S, Franco MC, Beckman JS, Estevez AG. Temporal patterns of tyrosine nitration in embryo heart development. Free Radic Biol Med. 2013;55:101–108. doi: 10.1016/j.freeradbiomed.2012.10.535. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Lancaster JR. Nitroxidative, nitrosative, and nitrative stress: kinetic predictions of reactive nitrogen species chemistry under biological conditions. Chem Res Toxicol. 2006;19(9):1160–1174. doi: 10.1021/tx060061w. [DOI] [PubMed] [Google Scholar]
- 42.Goldstein S, MerÈnyi G, Robert KP. Methods in enzymology. USA: Academic; 2008. The chemistry of peroxynitrite: implications for biological activity; pp. 49–61. [DOI] [PubMed] [Google Scholar]
- 43.Souza JM, Peluffo G, Radi R. Protein tyrosine nitration-functional alteration or just a biomarker? Free Radic Biol Med. 2008;45(4):357–366. doi: 10.1016/j.freeradbiomed.2008.04.010. [DOI] [PubMed] [Google Scholar]
- 44.Schopfer FJ, Baker PR, Freeman BA. NO-dependent protein nitration: a cell signaling event or an oxidative inflammatory response? Trends Biochem Sci. 2003;28(12):646–654. doi: 10.1016/j.tibs.2003.10.006. [DOI] [PubMed] [Google Scholar]
- 45.Greenacre SA, Ischiropoulos H. Tyrosine nitration: localisation, quantification, consequences for protein function and signal transduction. Free Radic Res. 2001;34(6):541–581. doi: 10.1080/10715760100300471. [DOI] [PubMed] [Google Scholar]
- 46.Ischiropoulos H, Beckman JS. Oxidative stress and nitration in neurodegeneration: cause, effect, or association? J Clin Invest. 2003;111(2):163–169. doi: 10.1172/JCI17638. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Aslan MM, Ozben TT. Reactive oxygen and nitrogen species in Alzheimer’s disease. Curr Alzheimer Res. 2004;1(2):111–119. doi: 10.2174/1567205043332162. [DOI] [PubMed] [Google Scholar]
- 48.Casoni F, Basso M, Massignan T, Gianazza E, Cheroni C, Salmona M, Bendotti C, Bonetto V. Protein nitration in a mouse model of familial amyotrophic lateral sclerosis: possible multifunctional role in the pathogenesis. J Biol Chem. 2005;280(16):16295–16304. doi: 10.1074/jbc.M413111200. [DOI] [PubMed] [Google Scholar]
- 49.Martin LJ, Price AC, Kaiser A, Shaikh AY, Liu Z. Mechanisms for neuronal degeneration in amyotrophic lateral sclerosis and in models of motor neuron death (Review) Int J Mol Med. 2000;5(1):3–13. doi: 10.3892/ijmm.5.1.3. [DOI] [PubMed] [Google Scholar]
- 50.Diaz-Sanchez MM, Williams KK, DeLuca GCGC, Esiri MMMM. Protein co-expression with axonal injury in multiple sclerosis plaques. Acta Neuropathol. 2006;111(4):289–299. doi: 10.1007/s00401-006-0045-0. [DOI] [PubMed] [Google Scholar]
- 51.Bizzozero OAOA, DeJesus GG, Bixler HAHA, Pastuszyn AA. Evidence of nitrosative damage in the brain white matter of patients with multiple sclerosis. Neurochem Res. 2005;30(1):139–149. doi: 10.1007/s11064-004-9695-2. [DOI] [PubMed] [Google Scholar]
- 52.Calabrese V, Scapagnini G, Ravagna A, Bella R, Foresti R, Bates TE, Stella A-MG, Pennisi G. Nitric oxide synthase is present in the cerebrospinal fluid of patients with active multiple sclerosis and is associated with increases in cerebrospinal fluid protein nitrotyrosine and S-nitrosothiols and with changes in glutathione levels. J Neurosci Res. 2002;70(4):580–587. doi: 10.1002/jnr.10408. [DOI] [PubMed] [Google Scholar]
- 53.Liu JSH, Zhao M-L, Brosnan CF, Lee SC. Expression of inducible nitric oxide synthase and nitrotyrosine in multiple sclerosis lesions. Am J Pathol. 2001;158(6):2057–2066. doi: 10.1016/S0002-9440(10)64677-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Cuzzocrea S, Riley DP, Caputi AP, Salvemini D. Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev. 2001;53(1):135–159. [PubMed] [Google Scholar]
- 55.Cuzzocrea S, Genovese T, Mazzon E, Crisafulli C, Di Paola R, Muia C, Collin M, Esposito E, Bramanti P, Thiemermann C. Glycogen synthase kinase-3beta inhibition reduces secondary damage in experimental spinal cord trauma. J Pharmacol Exp Ther. 2006;318(1):79–89. doi: 10.1124/jpet.106.102863. [DOI] [PubMed] [Google Scholar]
- 56.Genovese TT, Mazzon EE, Mariotto SS, Menegazzi MM, Cardali SS, Conti AA, Suzuki HH, Bramanti PP, Cuzzocrea SS. Modulation of nitric oxide homeostasis in a mouse model of spinal cord injury. J Neurosurg Spine. 2006;4(2):145–153. doi: 10.3171/spi.2006.4.2.145. [DOI] [PubMed] [Google Scholar]
- 57.Scott GS, Cuzzocrea S, Genovese T, Koprowski H, Hooper DC. Uric acid protects against secondary damage after spinal cord injury. PNAS. 2005;102(9):3483–3488. doi: 10.1073/pnas.0500307102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Lee Y-S, Sindhu RK, Lin C-Y, Ehdaie A, Lin VW, Vaziri ND. Effects of nerve graft on nitric oxide synthase, NAD(P)H oxidase, and antioxidant enzymes in chronic spinal cord injury. Free Radic Biol Med. 2004;36(3):330–339. doi: 10.1016/j.freeradbiomed.2003.11.006. [DOI] [PubMed] [Google Scholar]
- 59.Sakurai M, Fukuyama N, Takizawa S, Abe K, Hayashi T, Shinohara Y, Nakazawa H, Tabayashi K. Inductions of 3-L-nitrotyrosine in motor neurons after transient spinal cord ischemia in rabbits. J Cereb Blood Flow Metab. 1998;18(11):1233–1238. doi: 10.1097/00004647-199811000-00009. [DOI] [PubMed] [Google Scholar]
- 60.Go YM, Patel RP, Maland MC, Park H, Beckman JS, Darley-Usmar VM, Jo H. Evidence for peroxynitrite as a signaling molecule in flow-dependent activation of c-Jun NH(2)-terminal kinase. Am J Physiol. 1999;277(4 Pt 2):H1647–H1653. doi: 10.1152/ajpheart.1999.277.4.H1647. [DOI] [PubMed] [Google Scholar]
- 61.Souza JM, Daikhin E, Yudkoff M, Raman CS, Ischiropoulos H. Factors determining the selectivity of protein tyrosine nitration. Arch Biochem Biophys. 1999;371(2):169–178. doi: 10.1006/abbi.1999.1480. [DOI] [PubMed] [Google Scholar]
- 62.Ischiropoulos H, Gow A. Pathophysiological functions of nitric oxide-mediated protein modifications. Toxicology. 2005;208(2):299–303. doi: 10.1016/j.tox.2004.11.018. [DOI] [PubMed] [Google Scholar]
- 63.Ischiropoulos H. Biological tyrosine nitration: a pathophysiological function of nitric oxide and reactive oxygen species. Arch Biochem Biophys. 1998;356(1):1–11. doi: 10.1006/abbi.1998.0755. [DOI] [PubMed] [Google Scholar]
- 64.MacMillan-Crow LA, Greendorfer JS, Vickers SM, Thompson JA. Tyrosine nitration of c-SRC tyrosine kinase in human pancreatic ductal adenocarcinoma. Arch Biochem Biophys. 2000;377(2):350–356. doi: 10.1006/abbi.2000.1799. [DOI] [PubMed] [Google Scholar]
- 65.Ye Y, Quijano C, Robinson KM, Ricart KC, Strayer AL, Sahawneh MA, Shacka JJ, Kirk M, Barnes S, Accavitti-Loper MA, Radi R, Beckman JS, Estevez AG. Prevention of peroxynitrite-induced apoptosis of motor neurons and PC12 cells by tyrosine-containing peptides. J Biol Chem. 2007;282:6324–6337. doi: 10.1074/jbc.M610800200. [DOI] [PubMed] [Google Scholar]
- 66.Beckmann JS, Ye YZ, Anderson PG, Chen J, Accavitti MA, Tarpey MM, White CR. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Bio Chem Hoppe Seyler. 1994;375(2):81–88. doi: 10.1515/bchm3.1994.375.2.81. [DOI] [PubMed] [Google Scholar]
- 67.Lin K-T, Xue J-Y, Nomen M, Spur B, Wong PY-K. Peroxynitrite-induced apoptosis in HL-60 cells. J Biol Chem. 1995;270(28):16487–16490. doi: 10.1074/jbc.270.28.16487. [DOI] [PubMed] [Google Scholar]
- 68.Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, Lipton SA. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-d-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc Natl Acad Sci USA. 1995;92(16):7162–7166. doi: 10.1073/pnas.92.16.7162. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Estevez AG, Radi R, Barbeito L, Shin JT, Thompson JA, Beckman JS. Peroxynitrite-induced cytotoxicity in PC12 cells: evidence for an apoptotic mechanism differentially modulated by neurotrophic factors. J Neurochem. 1995;65(4):1543–1550. doi: 10.1046/j.1471-4159.1995.65041543.x. [DOI] [PubMed] [Google Scholar]
- 70.Salgo MG, Squadrito GL, Pryor WA. Peroxynitrite causes apoptosis in rat thymocytes. Biochem Biophys Res Commun. 1995;215(3):1111–1118. doi: 10.1006/bbrc.1995.2578. [DOI] [PubMed] [Google Scholar]
- 71.Troy CM, Derossi D, Prochiantz A, Greene LA, Shelanski ML. Downregulation of Cu/Zn superoxide dismutase leads to cell death via the nitric oxide-peroxynitrite pathway. J Neurosci. 1996;16(1):253–261. doi: 10.1523/JNEUROSCI.16-01-00253.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Estevez AG, Sampson JB, Zhuang YX, Spear N, Richardson GJ, Crow JP, Tarpey MM, Barbeito L, Beckman JS. Liposome-delivered superoxide dismutase prevents nitric oxide-dependent motor neuron death induced by trophic factor withdrawal. Free Radic Biol Med. 2000;28(3):437–446. doi: 10.1016/s0891-5849(99)00261-0. [DOI] [PubMed] [Google Scholar]
- 73.Estévez AG, Crow JP, Sampson JB, Reiter C, Zhuang Y-X, Richardson GJ, Tarpey MM, Barbeito L, Beckman JS. Induction of nitric oxide-dependent apoptosis in motor neurons by zinc-deficient superoxide dismutase. Science. 1999;286:2498–2500. doi: 10.1126/science.286.5449.2498. [DOI] [PubMed] [Google Scholar]
- 74.Raoul C, Estévez AG, Nishimune H, Cleveland DW, deLapeyrière O, Henderson CE, Haase G, Pettmann B. Motoneuron death triggered by a specific pathway downstream of fas: potentiation by ALS-linked SOD1 mutations. Neuron. 2002;35:1067–1083. doi: 10.1016/s0896-6273(02)00905-4. [DOI] [PubMed] [Google Scholar]
- 75.Spear N, Estevez AG, Barbeito L, Beckman JS, Johnson GV. Nerve growth factor protects PC12 cells against peroxynitrite-induced apoptosis via a mechanism dependent on phosphatidylinositol 3-kinase. J Neurochem. 1997;69(1):53–59. doi: 10.1046/j.1471-4159.1997.69010053.x. [DOI] [PubMed] [Google Scholar]
- 76.Spear N, Estévez AG, Johnson GVW, Bredesen DE, Thompson JA, Beckman JS. Enhancement of peroxynitrite-induced apoptosis in PC12 cells by FGF-1 and NGF requires p21Ras activation and is suppressed by Bcl-2. Arch Biochem Biophys. 1998;356:41–45. doi: 10.1006/abbi.1998.0741. [DOI] [PubMed] [Google Scholar]
- 77.Shin JT, Barbeito L, MacMillan-Crow LA, Beckman JS, Thompson JA. Acidic fibroblast growth factor enhances peroxynitrite-induced apoptosis in primary murine fibroblasts. Arch Biochem Biophys. 1996;335(1):32–41. doi: 10.1006/abbi.1996.0479. [DOI] [PubMed] [Google Scholar]
- 78.Ramezanian MS, Padmaja S, Koppenol WH. Nitration and hydroxylation of phenolic compounds by peroxynitrite. Chem Res Toxicol. 1996;9(1):232–240. doi: 10.1021/tx950135w. [DOI] [PubMed] [Google Scholar]
- 79.Alvarez B, Ferrer-Sueta G, Freeman BA, Radi R. Kinetics of peroxynitrite reaction with amino acids and human serum albumin. J Biol Chem. 1999;274(2):842–848. doi: 10.1074/jbc.274.2.842. [DOI] [PubMed] [Google Scholar]
- 80.Radi R. Nitric oxide, oxidants, and protein tyrosine nitration. Proc Natl Acad Sci USA. 2004;101(12):4003–4008. doi: 10.1073/pnas.0307446101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 81.Beckman JS, Ischiropoulos H, Zhu L, van der Woerd M, Smith C, Chen J, Harrison J, Martin JC, Tsai M. Kinetics of superoxide dismutase and iron-catalyzed nitration of phenolics by peroxynitrite. Arch Biochem Biophys. 1992;298(2):438–445. doi: 10.1016/0003-9861(92)90432-v. [DOI] [PubMed] [Google Scholar]
- 82.van der Vliet A, Eiserich JP, Halliwell B, Cross CE. Formation of reactive nitrogen species during peroxidase-catalyzed oxidation of nitrite. A potential additional mechanism of nitric oxide-dependent toxicity. J Biol Chem. 1997;272(12):7617–7625. doi: 10.1074/jbc.272.12.7617. [DOI] [PubMed] [Google Scholar]
- 83.Eiserich JP, Hristova M, Cross CE, Jones AD, Freeman BA, Halliwell B, van der Vliet A. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature. 1998;391(6665):393–397. doi: 10.1038/34923. [DOI] [PubMed] [Google Scholar]
- 84.Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem. 1991;266(7):4244–4250. [PubMed] [Google Scholar]
- 85.Brennan ML, Wu W, Fu X, Shen Z, Song W, Frost H, Vadseth C, Narine L, Lenkiewicz E, Borchers MT, Lusis AJ, Lee JJ, Lee NA, Abu-Soud HM, Ischiropoulos H, Hazen SL. A tale of two controversies: defining both the role of peroxidases in nitrotyrosine formation in vivo using eosinophil peroxidase and myeloperoxidase-deficient mice, and the nature of peroxidase-generated reactive nitrogen species. J Biol Chem. 2002;277(20):17415–17427. doi: 10.1074/jbc.M112400200. [DOI] [PubMed] [Google Scholar]
- 86.MacMillan-Crow LA, Crow JP, Kerby JD, Beckman JS, Thompson JA. Nitration and inactivation of manganese superoxide dismutase in chronic rejection of human renal allografts. Proc Natl Acad Sci USA. 1996;93(21):11853–11858. doi: 10.1073/pnas.93.21.11853. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 87.MacMillan-Crow LA, Thompson JA. Tyrosine modifications and inactivation of active site manganese superoxide dismutase mutant (Y34F) by peroxynitrite. Arch Biochem Biophys. 1999;366(1):82–88. doi: 10.1006/abbi.1999.1202. [DOI] [PubMed] [Google Scholar]
- 88.MacMillan-Crow LA, Crow JP, Thompson JA. Peroxynitrite-mediated inactivation of manganese superoxide dismutase involves nitration and oxidation of critical tyrosine residues. Biochemistry. 1998;37(6):1613–1622. doi: 10.1021/bi971894b. [DOI] [PubMed] [Google Scholar]
- 89.Yamakura F, Taka H, Fujimura T, Murayama K. Inactivation of human manganese-superoxide dismutase by peroxynitrite is caused by exclusive nitration of tyrosine 34 to 3-nitrotyrosine. J Biol Chem. 1998;273(23):14085–14089. doi: 10.1074/jbc.273.23.14085. [DOI] [PubMed] [Google Scholar]
- 90.Neumann H, Hazen JL, Weinstein J, Mehl RA, Chin JW. Genetically encoding protein oxidative damage. J Am Chem Soc. 2008;130(12):4028–4033. doi: 10.1021/ja710100d. [DOI] [PubMed] [Google Scholar]
- 91.Cruthirds DL, Novak L, Akhi KM, Sanders PW, Thompson JA, MacMillan-Crow LA. Mitochondrial targets of oxidative stress during renal ischemia/reperfusion. Arch Biochem Biophys. 2003;412(1):27–33. doi: 10.1016/s0003-9861(03)00039-0. [DOI] [PubMed] [Google Scholar]
- 92.Nilakantan V, Halligan NL, Nguyen TK, Hilton G, Khanna AK, Roza AM, Johnson CP, Adams MB, Griffith OW, Pieper GM. Post-translational modification of manganese superoxide dismutase in acutely rejecting cardiac transplants: role of inducible nitric oxide synthase. J Heart Lung Transplant Off Publ Int Soc Heart Transplant. 2005;24(10):1591–1599. doi: 10.1016/j.healun.2005.01.009. [DOI] [PubMed] [Google Scholar]
- 93.Bayir H, Kagan VE, Clark RS, Janesko-Feldman K, Rafikov R, Huang Z, Zhang X, Vagni V, Billiar TR, Kochanek PM. Neuronal NOS-mediated nitration and inactivation of manganese superoxide dismutase in brain after experimental and human brain injury. J Neurochem. 2007;101(1):168–181. doi: 10.1111/j.1471-4159.2006.04353.x. [DOI] [PubMed] [Google Scholar]
- 94.Redondo-Horcajo M, Romero N, Martinez-Acedo P, Martinez-Ruiz A, Quijano C, Lourenco CF, Movilla N, Enriquez JA, Rodriguez-Pascual F, Rial E, Radi R, Vazquez J, Lamas S. Cyclosporine A-induced nitration of tyrosine 34 MnSOD in endothelial cells: role of mitochondrial superoxide. Cardiovasc Res. 2010;87(2):356–365. doi: 10.1093/cvr/cvq028. [DOI] [PubMed] [Google Scholar]
- 95.Gray KD, MacMillan-Crow LA, Simovic MO, Stain SC, May AK. Pulmonary MnSOD is nitrated following hepatic ischemia-reperfusion. Surg infect. 2004;5(2):166–173. doi: 10.1089/sur.2004.5.166. [DOI] [PubMed] [Google Scholar]
- 96.Xu S, Ying J, Jiang B, Guo W, Adachi T, Sharov V, Lazar H, Menzoian J, Knyushko TV, Bigelow D, Schoneich C, Cohen RA. Detection of sequence-specific tyrosine nitration of manganese SOD and SERCA in cardiovascular disease and aging. Am J Physiol Heart Circ Physiol. 2006;290(6):H2220–H2227. doi: 10.1152/ajpheart.01293.2005. [DOI] [PubMed] [Google Scholar]
- 97.Quijano C, Hernandez-Saavedra D, Castro L, McCord JM, Freeman BA, Radi R. Reaction of peroxynitrite with Mn-superoxide dismutase. Role of the metal center in decomposition kinetics and nitration. J Biol Chem. 2001;276(15):11631–11638. doi: 10.1074/jbc.M009429200. [DOI] [PubMed] [Google Scholar]
- 98.Quijano C, Castro L, Peluffo G, Valez V, Radi R. Enhanced mitochondrial superoxide in hyperglycemic endothelial cells: direct measurements and formation of hydrogen peroxide and peroxynitrite. Am J Physiol Heart Circ Physiol. 2007;293(6):H3404–H3414. doi: 10.1152/ajpheart.00761.2007. [DOI] [PubMed] [Google Scholar]
- 99.Li Y, Huang TT, Carlson EJ, Melov S, Ursell PC, Olson JL, Noble LJ, Yoshimura MP, Berger C, Chan PH, Wallace DC, Epstein CJ. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet. 1995;11(4):376–381. doi: 10.1038/ng1295-376. [DOI] [PubMed] [Google Scholar]
- 100.Kokoszka JE, Coskun P, Esposito LA, Wallace DC. Increased mitochondrial oxidative stress in the Sod2 (±) mouse results in the age-related decline of mitochondrial function culminating in increased apoptosis. Proc Natl Acad Sci USA. 2001;98(5):2278–2283. doi: 10.1073/pnas.051627098. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 101.Wollman EE, d’Auriol L, Rimsky L, Shaw A, Jacquot JP, Wingfield P, Graber P, Dessarps F, Robin P, Galibert F, et al. Cloning and expression of a cDNA for human thioredoxin. J Biol Chem. 1988;263(30):15506–15512. [PubMed] [Google Scholar]
- 102.Tao L, Jiao X, Gao E, Lau WB, Yuan Y, Lopez B, Christopher T, RamachandraRao SP, Williams W, Southan G, Sharma K, Koch W, Ma XL. Nitrative inactivation of thioredoxin-1 and its role in postischemic myocardial apoptosis. Circulation. 2006;114(13):1395–1402. doi: 10.1161/CIRCULATIONAHA.106.625061. [DOI] [PubMed] [Google Scholar]
- 103.Yin T, Hou R, Liu S, Lau WB, Wang H, Tao L. Nitrative inactivation of thioredoxin-1 increases vulnerability of diabetic hearts to ischemia/reperfusion injury. J Mol Cell Cardiol. 2010;49(3):354–361. doi: 10.1016/j.yjmcc.2010.05.002. [DOI] [PubMed] [Google Scholar]
- 104.Cassina AM, Hodara R, Souza JM, Thomson L, Castro L, Ischiropoulos H, Freeman BA, Radi R. Cytochrome c nitration by peroxynitrite. J Biol Chem. 2000;275(28):21409–21415. doi: 10.1074/jbc.M909978199. [DOI] [PubMed] [Google Scholar]
- 105.MacMillan-Crow LA, Cruthirds DL, Ahki KM, Sanders PW, Thompson JA. Mitochondrial tyrosine nitration precedes chronic allograft nephropathy. Free Radic Biol Med. 2001;31(12):1603–1608. doi: 10.1016/s0891-5849(01)00750-x. [DOI] [PubMed] [Google Scholar]
- 106.Abriata LA, Cassina A, Tortora V, Marin M, Souza JM, Castro L, Vila AJ, Radi R. Nitration of solvent-exposed tyrosine 74 on cytochrome c triggers heme iron-methionine 80 bond disruption. Nuclear magnetic resonance and optical spectroscopy studies. J Biol Chem. 2009;284(1):17–26. doi: 10.1074/jbc.M807203200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 107.Castro L, Eiserich JP, Sweeney S, Radi R, Freeman BA. Cytochrome c: a catalyst and target of nitrite-hydrogen peroxide-dependent protein nitration. Arch Biochem Biophys. 2004;421(1):99–107. doi: 10.1016/j.abb.2003.08.033. [DOI] [PubMed] [Google Scholar]
- 108.Souza JM, Castro L, Cassina AM, Batthyany C, Radi R. Nitrocytochrome c: synthesis, purification, and functional studies. Methods Enzymol. 2008;441:197–215. doi: 10.1016/S0076-6879(08)01211-1. [DOI] [PubMed] [Google Scholar]
- 109.Rodriguez-Roldan V, Garcia-Heredia JM, Navarro JA, De la Rosa MA, Hervas M. Effect of nitration on the physicochemical and kinetic features of wild-type and monotyrosine mutants of human respiratory cytochrome c. Biochemistry. 2008;47(47):12371–12379. doi: 10.1021/bi800910v. [DOI] [PubMed] [Google Scholar]
- 110.Garcia-Heredia JM, Diaz-Moreno I, Nieto PM, Orzaez M, Kocanis S, Teixeira M, Perez-Paya E, Diaz-Quintana A, De la Rosa MA. Nitration of tyrosine 74 prevents human cytochrome c to play a key role in apoptosis signaling by blocking caspase-9 activation. Biochim Biophys Acta. 2010;1797(6–7):981–993. doi: 10.1016/j.bbabio.2010.03.009. [DOI] [PubMed] [Google Scholar]
- 111.Garcia-Heredia JM, Diaz-Moreno I, Diaz-Quintana A, Orzaez M, Navarro JA, Hervas M, De la Rosa MA. Specific nitration of tyrosines 46 and 48 makes cytochrome c assemble a non-functional apoptosome. FEBS Lett. 2012;586(2):154–158. doi: 10.1016/j.febslet.2011.12.007. [DOI] [PubMed] [Google Scholar]
- 112.Diaz-Moreno I, Garcia-Heredia JM, Diaz-Quintana A, Teixeira M, De la Rosa MA. Nitration of tyrosines 46 and 48 induces the specific degradation of cytochrome c upon change of the heme iron state to high-spin. Biochim Biophys Acta. 2011;1807(12):1616–1623. doi: 10.1016/j.bbabio.2011.09.012. [DOI] [PubMed] [Google Scholar]
- 113.Ara J, Przedborski S, Naini AB, Jackson-Lewis V, Trifiletti RR, Horwitz J, Ischiropoulos H. Inactivation of tyrosine hydroxylase by nitration following exposure to peroxynitrite and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP) Proc Natl Acad Sci USA. 1998;95(13):7659–7663. doi: 10.1073/pnas.95.13.7659. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 114.Blanchard-Fillion B, Prou D, Polydoro M, Spielberg D, Tsika E, Wang Z, Hazen SL, Koval M, Przedborski S, Ischiropoulos H. Metabolism of 3-nitrotyrosine induces apoptotic death in dopaminergic cells. J Neurosci. 2006;26(23):6124–6130. doi: 10.1523/JNEUROSCI.1038-06.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 115.Giasson BI, Duda JE, Murray IV, Chen Q, Souza JM, Hurtig HI, Ischiropoulos H, Trojanowski JQ. Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions. Science. 2000;290(5493):985–989. doi: 10.1126/science.290.5493.985. [DOI] [PubMed] [Google Scholar]
- 116.Duda JE, Giasson BI, Chen Q, Gur TL, Hurtig HI, Stern MB, Gollomp SM, Ischiropoulos H, Lee VM, Trojanowski JQ. Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies. Am J Pathol. 2000;157(5):1439–1445. doi: 10.1016/S0002-9440(10)64781-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 117.McCormack AL, Mak SK, Di Monte DA. Increased alpha-synuclein phosphorylation and nitration in the aging primate substantia nigra. Cell Death Dis. 2012;3:e315. doi: 10.1038/cddis.2012.50. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 118.Benner EJ, Banerjee R, Reynolds AD, Sherman S, Pisarev VM, Tsiperson V, Nemachek C, Ciborowski P, Przedborski S, Mosley RL, Gendelman HE. Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons. PLoS One. 2008;3(1):e1376. doi: 10.1371/journal.pone.0001376. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 119.Souza JM, Giasson BI, Chen Q, Lee VM, Ischiropoulos H. Dityrosine cross-linking promotes formation of stable alpha-synuclein polymers. Implication of nitrative and oxidative stress in the pathogenesis of neurodegenerative synucleinopathies. J Biol Chem. 2000;275(24):18344–18349. doi: 10.1074/jbc.M000206200. [DOI] [PubMed] [Google Scholar]
- 120.Liu Y, Qiang M, Wei Y, He R. A novel molecular mechanism for nitrated {alpha}-synuclein-induced cell death. J Mol Cell Biol. 2011;3(4):239–249. doi: 10.1093/jmcb/mjr011. [DOI] [PubMed] [Google Scholar]
- 121.Franco MC, Ye Y, Refakis CA, Feldman JL, Stokes AL, Basso M, Melero Fernandez de Mera RM, Sparrow NA, Calingasan NY, Kiaei M, Rhoads TW, Ma TC, Grumet M, Barnes S, Beal MF, Beckman JS, Mehl R, Estevez AG. Nitration of Hsp90 induces cell death. Proc Natl Acad Sci USA. 2013;110(12):E1102–E1111. doi: 10.1073/pnas.1215177110. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 122.Borkovich KA, Farrelly FW, Finkelstein DB, Taulien J, Lindquist S. hsp82 is an essential protein that is required in higher concentrations for growth of cells at higher temperatures. Mol Cell Biol. 1989;9(9):3919–3930. doi: 10.1128/mcb.9.9.3919. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 123.Didelot C, Schmitt E, Brunet M, Maingret L, Parcellier A, Garrido C. Heat shock proteins: endogenous modulators of apoptotic cell death. Handbook of experimental pharmacology. 2006;172:171–198. doi: 10.1007/3-540-29717-0_8. [DOI] [PubMed] [Google Scholar]
- 124.Wiech H, Buchner J, Zimmermann R, Jakob U. Hsp90 chaperones protein folding in vitro. Nature. 1992;358(6382):169–170. doi: 10.1038/358169a0. [DOI] [PubMed] [Google Scholar]
- 125.Wandinger SK, Richter K, Buchner J. The Hsp90 chaperone machinery. J Biol Chem. 2008;283(27):18473–18477. doi: 10.1074/jbc.R800007200. [DOI] [PubMed] [Google Scholar]
- 126.Wu Z, MoghaddasGholami A, Kuster B (2012) Systematic identification of the HSP90 candidate regulated proteome. Mol Cell Proteomics MCP 11(6):M111.016675. doi:10.1074/mcp.M111.016675 [DOI] [PMC free article] [PubMed]
- 127.Pearl LH, Prodromou C. Structure and mechanism of the Hsp90 molecular chaperone machinery. Annu Rev Biochem. 2006;75:271–294. doi: 10.1146/annurev.biochem.75.103004.142738. [DOI] [PubMed] [Google Scholar]
- 128.Cunningham CN, Krukenberg KA, Agard DA. Intra- and intermonomer interactions are required to synergistically facilitate ATP hydrolysis in Hsp90. J Biol Chem. 2008;283(30):21170–21178. doi: 10.1074/jbc.M800046200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 129.Bian K, Murad F. Diversity of endotoxin-induced nitrotyrosine formation in macrophage-endothelium-rich organs. Free Radic Biol Med. 2001;31(4):421–429. doi: 10.1016/s0891-5849(01)00600-1. [DOI] [PubMed] [Google Scholar]